Savior Lifetec (4167) Stock Overview
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
4167 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Savior Lifetec Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$17.30 |
| 52 Week High | NT$22.10 |
| 52 Week Low | NT$14.35 |
| Beta | 0.26 |
| 1 Month Change | -4.16% |
| 3 Month Change | -1.70% |
| 1 Year Change | -18.01% |
| 3 Year Change | -21.36% |
| 5 Year Change | -43.33% |
| Change since IPO | -33.01% |
Recent News & Updates
Recent updates
Is Savior Lifetec (GTSM:4167) Using Too Much Debt?
Mar 29
Update: Savior Lifetec (GTSM:4167) Stock Gained 35% In The Last Five Years
Feb 22Savior Lifetec Corporation (GTSM:4167) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Jan 25Should You Use Savior Lifetec's (GTSM:4167) Statutory Earnings To Analyse It?
Dec 29Savior Lifetec (GTSM:4167) Seems To Use Debt Quite Sensibly
Dec 03
Shareholder Returns
| 4167 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -4.2% | -1.4% | 6.1% |
| 1Y | -18.0% | 12.9% | 27.9% |
Return vs Industry: 4167 underperformed the TW Pharmaceuticals industry which returned 13.8% over the past year.
Return vs Market: 4167 underperformed the TW Market which returned 26.6% over the past year.
Price Volatility
| 4167 volatility | |
|---|---|
| 4167 Average Weekly Movement | 3.0% |
| Pharmaceuticals Industry Average Movement | 4.3% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.3% |
| 10% least volatile stocks in TW Market | 2.0% |
Stable Share Price: 4167 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4167's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Freon Chen | www.saviorlifetec.com.tw/en |
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products.
Savior Lifetec Corporation Fundamentals Summary
| 4167 fundamental statistics | |
|---|---|
| Market cap | NT$5.37b |
| Earnings (TTM) | NT$495.76m |
| Revenue (TTM) | NT$1.16b |
Is 4167 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4167 income statement (TTM) | |
|---|---|
| Revenue | NT$1.16b |
| Cost of Revenue | NT$749.73m |
| Gross Profit | NT$409.03m |
| Other Expenses | -NT$86.72m |
| Earnings | NT$495.76m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.60 |
| Gross Margin | 35.30% |
| Net Profit Margin | 42.78% |
| Debt/Equity Ratio | 0% |
How did 4167 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/06 07:47 |
| End of Day Share Price | 2026/01/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Savior Lifetec Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yenya Kuo | Capital Securities Corporation |
| Xiaowei Huang | Masterlink Securities Corp. |